Our Impact
Through direct funding, institutional partnership, and long-term commitment, we support innovative therapies being developed and tested at MD Anderson Cancer Center.
Our Endowment
Jamie’s Hope established an endowed fund at The University of Texas MD Anderson Cancer Center to ensure long-term support for innovative, experimental therapies within the Department of Investigational Cancer Therapeutics.
Our Leadership
Dr. Tsimberidou is an internationally recognized physician-scientist and leader in precision oncology, known for advancing molecularly targeted therapies for patients with advanced and rare cancers.
Dr. Apostolia Tsimberidou, MD, PhD
Through Jamie’s Hope’s endowed support,
Dr. Tsimberidou’s work continues to push the boundaries of cancer care, translating research into real world impact for patients and families. This partnership represents a long term investment in innovation, compassion, and the belief that better answers are possible.
Video by Bryan Anderson Edited by Zenith Creative
1600+
Patients Per Year
40+
Scientific publications supported
$350K+
Funded for targeted therapy research
.jpg)
